propofol + midazolam

Propofol + midazolam is a combination of two intravenous sedative agents used together for procedural sedation, anesthesia induction and maintenance, and intensive care unit (ICU) sedation. Propofol is a short-acting hypnotic agent that acts primarily as a positive allosteric modulator of the gamma-aminobutyric acid type A (GABA-A) receptor, leading to central nervous system depression and rapid onset of unconsciousness. Midazolam is a short-acting benzodiazepine that also enhances GABA-A receptor activity but at a different binding site, providing anxiolytic, amnestic, anticonvulsant, and sedative effects. When used in combination, these drugs exhibit synergistic effects on sedation and hypnosis—allowing for lower doses of each drug to achieve the desired level of anesthesia or sedation while potentially reducing adverse cardiovascular events compared to propofol alone[1][2][7]. This combination is commonly employed in ICU settings for mechanically ventilated patients or during procedures requiring deep sedation[1][7]. The use of both drugs together can minimize individual side effects such as cardiovascular depression from propofol or delayed recovery from midazolam accumulation[8].

Brand names

DiprivanVersed

Other names

Propofol/MidazolamPropofol and Midazolam